THE PSYCHOLOGICAL LANDSCAPE OF CANCER IMMUNOTHERAPY, NAVIGATING THE EMOTIONAL CHALLENGES OF NOVEL TREATMENTS
Main Article Content
Keywords
Cancer immunotherapy, Emotional challenges, Psychological impact, Patient coping mechanisms, Novel cancer treatments, Mental health in cancer patients, Anxiety and depression, Patient support systems, Psychological resilience
Abstract
Cancer immunotherapy has transformed oncology and given patients new hope. It includes cutting-edge therapies like immune checkpoint inhibitors and CAR-T cell therapy. The quick development of these treatments, however, brings with them severe psychological difficulties. Due to the unique and unpredictable nature of immunotherapy, patients frequently experience increased levels of anxiety, uncertainty, and emotional discomfort.
Feelings of fear and loneliness may worsen as a result of the treatment's protracted and challenging course and possible adverse consequences. This review explores how patients' emotional responses to cancer immunotherapy affect their well-being and the course of their treatment, delving into the psychological terrain around this approach. It emphasizes mental health providers' vital role in offering assistance and promoting an integrated care strategy considering patient care's medical and psychological components. This study emphasizes the significance of holistic patient care, where emotional and psychological support is smoothly incorporated into the treatment process, by concentrating on the confluence between immunotherapy and mental health. Improving the general quality of life for cancer patients receiving immunotherapy and ensuring that advancements in treatment match advancements in patient care depend on understanding and attention to these psychological aspects.
References
1. Abdullah, T., & Brown, T. L. (2011). Mental illness stigma and ethnocultural beliefs, values, and norms: An integrative review. Clinical Psychology Review, 31(6), 934-948.
2. Alemanno, F., Houdayer, E., Emedoli, D., Locatelli, M., Mortini, P., Mandelli, C., ... & Iannaccone, S. (2019). Efficacy of virtual reality to reduce chronic low back pain: Proof-of-concept of a non-pharmacological approach on pain, quality of life, neuropsychological and functional outcome. PloS one, 14(5), e0216858.
3. Alotaibi, A., & Sas, C. (2023, August). Review of AI-Based Mental Health Apps. In 36th International BCS Human-Computer Interaction Conference (pp. 238-250). BCS Learning & Development.
4. Apolinário-Hagen, J., Drüge, M., & Fritsche, L. (2020). Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: integrating traditional with digital treatment approaches. Anxiety disorders: Rethinking and understanding recent discoveries, 291-329.
5. Apolinário-Hagen, J., Drüge, M., & Fritsche, L. (2020). Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: integrating traditional with digital treatment approaches. Anxiety disorders: Rethinking and understanding recent discoveries, 291-329.
6. Barak, Y. (2006). The immune system and happiness. Autoimmunity reviews, 5(8), 523–527.
7. Boulanger, M. C., Falade, A. S., Hsu, K., Sommer, R. K., Zhou, A., Sarathy, R., ... & Petrillo, L. A. (2024). Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study. JCO Oncology Practice, OP-24.
8. Dai, S., Mo, Y., Wang, Y., Xiang, B., Liao, Q., Zhou, M., ... & Zeng, Z. (2020). Chronic stress promotes cancer development—frontiers in oncology, 10, 1492.
9. Darnell, D., Pullmann, M. D., Hull, T. D., Chen, S., & Areán, P. (2022). Predictors of disengagement and symptom improvement among adults with depression enrolled in talkspace, a technology-mediated psychotherapy platform: naturalistic observational study. JMIR Formative Research, 6(6), e36521.
10. Dienstbier, R. A. (1989). Arousal and physiological toughness: implications for mental and physical health. Psychological review, 96(1), 84.
11. Dunn Galvin, A., & Hourihane, J. O. B. (2018). Psychosocial mediators of change and patient selection factors in oral immunotherapy trials. Clinical reviews in allergy & immunology, 55(2), 217–236.
12. Dunn Galvin, A., & Hourihane, J. O. B. (2018). Psychosocial mediators of change and patient selection factors in oral immunotherapy trials. Clinical reviews in allergy & immunology, 55(2), 217–236.
13. Dwyer, A., de Almeida Neto, A., Estival, D., Li, W., Lam-Cassettari, C., & Antoniou, M. (2021). Suitability of text-based communications for the delivery of psychological therapeutic services to rural and remote communities: scoping review. JMIR mental health, 8(2), e19478.
14. Dwyer, D. B., Falkai, P., & Koutsouleris, N. (2018). Machine learning approaches for clinical psychology and psychiatry. Annual review of clinical psychology, 14(1), 91–118.
15. Eicher, M., Matzka, M., Dubey, C., & White, K. (2015, January). Resilience in adult cancer care: an integrative literature review. In Oncology Nursing Forum (Vol. 42, No. 1).
16. Emens, L. A., Ascierto, P. A., Darcy, P. K., Demaria, S., Eggermont, A. M., Redmond, W. L., ... & Marincola, F. M. (2017). Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape. European journal of cancer, 81, 116-129.
17. Focht‐Birkerts, L., & Beardslee, W. R. (2000). A child's experience of parental depression: Encouraging relational resilience in families with affective illness. Family Process, 39(4), 417–434.
18. Folkman, S. (1984). Personal control and stress and coping processes: a theoretical analysis. Journal of personality and social psychology, 46(4), 839.
19. Gaggioli, A., Riva, G., Peters, D., & Calvo, R. A. (2017). Positive technology, computing, and design: shaping a future in which technology promotes psychological well-being. In Emotions and affect in human factors and human-computer interaction (pp. 477-502). Academic press.
20. Geffen, J. R. (2004). Creating optimal healing environments for patients with cancer and their families: insights, challenges, and lessons learned from a decade of experience. Journal of Alternative & Complementary Medicine, 10(Supplement 1), S-93.
21. Geng, F., Wang, Z., Yin, H., Yu, J., & Cao, B. (2017). Molecular targeted drugs and treatment of colorectal cancer: recent progress and future perspectives. Cancer biotherapy & radiopharmaceuticals, 32(5), 149-160.
22. Gorini, A., & Riva, G. (2008). Virtual reality in anxiety disorders: the past and the future. Expert Review of Neurotherapeutics, 8(2), 215-233.
23. Hamre-Os, A. (2021). A mood tracking interface for the mobile application to help assess well-being in students (Master's thesis, The University of Bergen).
24. Herlitz, A., Munthe, C., Törner, M., & Forsander, G. (2016). The counseling, self-care, adherence approach to person-centered care and shared decision making: moral psychology, executive autonomy, and ethics in multi-dimensional care decisions. Health communication, 31(8), 964-973.
25. Huberty, J., Vranceanu, A. M., Carney, C., Breus, M., Gordon, M., & Puzia, M. E. (2019). Characteristics and usage patterns among 12,151 paid subscribers of the calm meditation app: cross-sectional survey. JMIR mHealth and uHealth, 7(11), e15648.
26. Jennings, S., Anstey, S., Bower, J., Brewster, A., Buckman, J., Fenlon, D., ... & Watts, T. (2021). Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm) insights of people affected by cancer and healthcare professionals: a qualitative study protocol. BMJ open, 11(5), e043750.
27. Jiang, M., Zhao, Q., Li, J., Wang, F., He, T., Cheng, X., ... & Fu, G. (2024). A Generic Review of Integrating Artificial Intelligence in Cognitive Behavioral Therapy. arXiv preprint arXiv:2407.19422.
28. Jongerius, C., Vermeulen, L., van Egmond, M., Evers, A. W. M., Buffart, L. M., & Lenos, K. J. (2022). Behavioral factors to modulate immunotherapy efficacy in cancer. Frontiers in immunology, 13, 1066359.
29. Kazdin, A. E., & Blase, S. L. (2011). Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspectives on psychological science, 6(1), 21-37.
30. Kazdin, A. E., & Rabbitt, S. M. (2013). Novel models for delivering mental health services and reducing the burdens of mental illness. Clinical Psychological Science, 1(2), 170-191.
31. Kazdin, A. E., & Rabbitt, S. M. (2013). Novel models for delivering mental health services and reducing the burdens of mental illness. Clinical Psychological Science, 1(2), 170-191.
32. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., & Glaser, R. (2002). Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annual review of psychology, 53(1), 83–107.
33. Levy, N. (2014). Forced to be free? Increasing patient autonomy by constraining it. Journal of Medical Ethics, 40(5), 293–300.
34. Little, M., & Sayers, E. J. (2004). While there is life…: hope and the experience of cancer. Social science & medicine, 59(6), 1329-1337.
35. Loftus, T. J., Filiberto, A. C., Rosenthal, M. D., Arnaoutakis, G. J., Sarosi Jr, G. A., Dimick, J. B., & Upchurch Jr, G. R. (2020). Performance advantages for grit and optimism. The American Journal of Surgery, 220(1), 10-18.
36. Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., ... & Wittchen, H. U. (2020). The clinical characterization of adult patients with depression is aimed at the personalization of management. World Psychiatry, 19(3), 269-293.
37. Mani, M., Kavanagh, D. J., Hides, L., & Stoyanov, S. R. (2015). Review and evaluation of mindfulness-based iPhone apps. JMIR mHealth and uHealth, 3(3), e4328.
38. Mar, R. A., & Oatley, K. (2008). The function of fiction is the abstraction and simulation of social experience. Perspectives on psychological science, 3(3), 173-192.
39. Martínez-Martí, M. L., & Ruch, W. (2017). Character strengths predict resilience over and above positive affect, self-efficacy, optimism, social support, self-esteem, and life satisfaction. The Journal of Positive Psychology, 12(2), 110-119.
40. Nasir, A., Khan, A., Li, J., Naeem, M., Khalil, A. A., Khan, K., & Qasim, M. (2021). Nanotechnology is a tool for diagnostics and treatment of cancer. Current topics in medicinal chemistry, 21(15), 1360-1376.
41. Naylor, C., Das, P., Ross, S., Honeyman, M., Thompson, J., & Gilburt, H. (2016). Bringing together physical and mental health. King's Fund, 109(10), 364–366.
42. Olawade, D. B., Wada, O. Z., Odetayo, A., David-Olawade, A. C., Asaolu, F., & Eberhardt, J. (2024). Enhancing mental health with Artificial Intelligence: Current trends and prospects. Journal of medicine, surgery, and public health, 100099.
43. Ortega, M. A., García-Montero, C., Fraile-Martinez, O., Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Lahera, G., ... & Álvarez-Mon, M. (2022). Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology. Biology, 11(7), 973.
44. Ortega, M. A., García-Montero, C., Fraile-Martinez, O., Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Lahera, G., ... & Álvarez-Mon, M. (2022). Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology. Biology, 11(7), 973.
45. Panter-Brick, C., & Eggerman, M. (2011). Understanding culture, resilience, and mental health: The production of hope. In The social ecology of resilience: A handbook of theory and practice (pp. 369-386). New York, NY: Springer, New York.
46. Park, R., Shaw, J. W., Korn, A., & McAuliffe, J. (2020). The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life. Journal of Cancer Survivorship, pp. 14, 363–376.
47. Rahman, M. M., Behl, T., Islam, M. R., Alam, M. N., Islam, M. M., Albarrati, A., ... & Bungau, S. G. (2022). Emerging management approach for the adverse events of immunotherapy of cancer. Molecules, 27(12), 3798.
48. Rasool, S., Ali, M., Shahroz, H. M., Hussain, H. K., & Gill, A. Y. (2024). Innovations in AI-Powered Healthcare: Transforming Cancer Treatment with Innovative Methods. BULLET: Jurnal Multidisiplin Ilmu, 3(1), 118-128.
49. Rohan, J. M., & Verma, T. (2020). Psychological considerations in pediatric chronic illness: case examples. International Journal of Environmental Research and Public Health, 17(5), 1644.
50. Salmon, J. W., Thompson, S. L., Salmon, J. W., & Thompson, S. L. (2021). Big data: information technology as control over the profession of medicine. The Corporatization of American Health Care: The Rise of Corporate Hegemony and the Loss of Professional Autonomy, pp. 181–254.
51. Seiler, A., & Jenewein, J. (2019). Resilience in cancer patients. Frontiers in psychiatry, 10, 208.
52. Shareef, M. A., Kumar, V., Dwivedi, Y. K., Kumar, U., Akram, M. S., & Raman, R. (2021). A new health care system enabled by machine intelligence: Elderly people's trust or losing self control. Technological Forecasting and Social Change, p. 162, 120334.
53. Sharf, B. F., & Vanderford, M. L. (2003). Illness narratives and the social construction of health. In The Routledge Handbook of health communication (pp. 23-48). Routledge.
54. Standish, L. J., Malani, S. M., Lynch, K., Whinkin, E. J., McCotter, C. M., Lynch, D. A., & Aggarwal, S. K. (2023). Integrative oncology’s 30th anniversary: What have we achieved? A North American naturopathic oncology perspective. Integrative Cancer Therapies, p. 22, 15347354231178911.
55. Stein, K. D., Syrjala, K. L., & Andrykowski, M. A. (2008). Physical and psychological long‐term and late effects of cancer. Cancer, 112(S11), 2577-2592.
56. Tavakolpour, S., & Karami, F. (2021). Cancer nanomedicine: Special focus on cancer immunotherapy. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, 465-508.
57. Temel, J. S., Petrillo, L. A., & Greer, J. A. (2022). Patient-centered palliative care for patients with advanced lung cancer. Journal of Clinical Oncology, 40(6), 626–634.
58. Tribe, R., & Bell, D. (2018). Social justice, diversity, and leadership. The European Journal of Counselling Psychology, 7(1), 111-125.
59. Turk, D. C., Fillingim, R. B., Ohrbach, R., & Patel, K. V. (2016). Assessment of the psychosocial and functional impact of chronic pain. The Journal of Pain, 17(9), T21-T49.
60. van Dulmen, S., Sluijs, E., Van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J. (2007). Patient adherence to medical treatment: a review of reviews. BMC health services research, 7, 1-13.
61. Weeks, J. C., Catalano, P. J., Cronin, A., Finkelman, M. D., Mack, J. W., Keating, N. L., & Schrag, D. (2012). Patients' expectations about effects of chemotherapy for advanced cancer. New England Journal of Medicine, 367(17), 1616-1625.
62. Williams, D. R., Mohammed, S. A., Leavell, J., & Collins, C. (2010). Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Annals of the New York Academy of Sciences, 1186(1), 69–101.
63. Yazdanpanah, N., Mojtabavi, H., Ziaei, H., Pirkoohi, Z. R., Rayzan, E., & Rezaei, N. (2022). The clinical benefits of art therapy: definition, history, and outcomes with a focus on music therapy. In Multidisciplinarity and interdisciplinarity in health (pp. 457-482). Cham: Springer International Publishing.
2. Alemanno, F., Houdayer, E., Emedoli, D., Locatelli, M., Mortini, P., Mandelli, C., ... & Iannaccone, S. (2019). Efficacy of virtual reality to reduce chronic low back pain: Proof-of-concept of a non-pharmacological approach on pain, quality of life, neuropsychological and functional outcome. PloS one, 14(5), e0216858.
3. Alotaibi, A., & Sas, C. (2023, August). Review of AI-Based Mental Health Apps. In 36th International BCS Human-Computer Interaction Conference (pp. 238-250). BCS Learning & Development.
4. Apolinário-Hagen, J., Drüge, M., & Fritsche, L. (2020). Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: integrating traditional with digital treatment approaches. Anxiety disorders: Rethinking and understanding recent discoveries, 291-329.
5. Apolinário-Hagen, J., Drüge, M., & Fritsche, L. (2020). Cognitive behavioral therapy, mindfulness-based cognitive therapy and acceptance commitment therapy for anxiety disorders: integrating traditional with digital treatment approaches. Anxiety disorders: Rethinking and understanding recent discoveries, 291-329.
6. Barak, Y. (2006). The immune system and happiness. Autoimmunity reviews, 5(8), 523–527.
7. Boulanger, M. C., Falade, A. S., Hsu, K., Sommer, R. K., Zhou, A., Sarathy, R., ... & Petrillo, L. A. (2024). Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study. JCO Oncology Practice, OP-24.
8. Dai, S., Mo, Y., Wang, Y., Xiang, B., Liao, Q., Zhou, M., ... & Zeng, Z. (2020). Chronic stress promotes cancer development—frontiers in oncology, 10, 1492.
9. Darnell, D., Pullmann, M. D., Hull, T. D., Chen, S., & Areán, P. (2022). Predictors of disengagement and symptom improvement among adults with depression enrolled in talkspace, a technology-mediated psychotherapy platform: naturalistic observational study. JMIR Formative Research, 6(6), e36521.
10. Dienstbier, R. A. (1989). Arousal and physiological toughness: implications for mental and physical health. Psychological review, 96(1), 84.
11. Dunn Galvin, A., & Hourihane, J. O. B. (2018). Psychosocial mediators of change and patient selection factors in oral immunotherapy trials. Clinical reviews in allergy & immunology, 55(2), 217–236.
12. Dunn Galvin, A., & Hourihane, J. O. B. (2018). Psychosocial mediators of change and patient selection factors in oral immunotherapy trials. Clinical reviews in allergy & immunology, 55(2), 217–236.
13. Dwyer, A., de Almeida Neto, A., Estival, D., Li, W., Lam-Cassettari, C., & Antoniou, M. (2021). Suitability of text-based communications for the delivery of psychological therapeutic services to rural and remote communities: scoping review. JMIR mental health, 8(2), e19478.
14. Dwyer, D. B., Falkai, P., & Koutsouleris, N. (2018). Machine learning approaches for clinical psychology and psychiatry. Annual review of clinical psychology, 14(1), 91–118.
15. Eicher, M., Matzka, M., Dubey, C., & White, K. (2015, January). Resilience in adult cancer care: an integrative literature review. In Oncology Nursing Forum (Vol. 42, No. 1).
16. Emens, L. A., Ascierto, P. A., Darcy, P. K., Demaria, S., Eggermont, A. M., Redmond, W. L., ... & Marincola, F. M. (2017). Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape. European journal of cancer, 81, 116-129.
17. Focht‐Birkerts, L., & Beardslee, W. R. (2000). A child's experience of parental depression: Encouraging relational resilience in families with affective illness. Family Process, 39(4), 417–434.
18. Folkman, S. (1984). Personal control and stress and coping processes: a theoretical analysis. Journal of personality and social psychology, 46(4), 839.
19. Gaggioli, A., Riva, G., Peters, D., & Calvo, R. A. (2017). Positive technology, computing, and design: shaping a future in which technology promotes psychological well-being. In Emotions and affect in human factors and human-computer interaction (pp. 477-502). Academic press.
20. Geffen, J. R. (2004). Creating optimal healing environments for patients with cancer and their families: insights, challenges, and lessons learned from a decade of experience. Journal of Alternative & Complementary Medicine, 10(Supplement 1), S-93.
21. Geng, F., Wang, Z., Yin, H., Yu, J., & Cao, B. (2017). Molecular targeted drugs and treatment of colorectal cancer: recent progress and future perspectives. Cancer biotherapy & radiopharmaceuticals, 32(5), 149-160.
22. Gorini, A., & Riva, G. (2008). Virtual reality in anxiety disorders: the past and the future. Expert Review of Neurotherapeutics, 8(2), 215-233.
23. Hamre-Os, A. (2021). A mood tracking interface for the mobile application to help assess well-being in students (Master's thesis, The University of Bergen).
24. Herlitz, A., Munthe, C., Törner, M., & Forsander, G. (2016). The counseling, self-care, adherence approach to person-centered care and shared decision making: moral psychology, executive autonomy, and ethics in multi-dimensional care decisions. Health communication, 31(8), 964-973.
25. Huberty, J., Vranceanu, A. M., Carney, C., Breus, M., Gordon, M., & Puzia, M. E. (2019). Characteristics and usage patterns among 12,151 paid subscribers of the calm meditation app: cross-sectional survey. JMIR mHealth and uHealth, 7(11), e15648.
26. Jennings, S., Anstey, S., Bower, J., Brewster, A., Buckman, J., Fenlon, D., ... & Watts, T. (2021). Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm) insights of people affected by cancer and healthcare professionals: a qualitative study protocol. BMJ open, 11(5), e043750.
27. Jiang, M., Zhao, Q., Li, J., Wang, F., He, T., Cheng, X., ... & Fu, G. (2024). A Generic Review of Integrating Artificial Intelligence in Cognitive Behavioral Therapy. arXiv preprint arXiv:2407.19422.
28. Jongerius, C., Vermeulen, L., van Egmond, M., Evers, A. W. M., Buffart, L. M., & Lenos, K. J. (2022). Behavioral factors to modulate immunotherapy efficacy in cancer. Frontiers in immunology, 13, 1066359.
29. Kazdin, A. E., & Blase, S. L. (2011). Rebooting psychotherapy research and practice to reduce the burden of mental illness. Perspectives on psychological science, 6(1), 21-37.
30. Kazdin, A. E., & Rabbitt, S. M. (2013). Novel models for delivering mental health services and reducing the burdens of mental illness. Clinical Psychological Science, 1(2), 170-191.
31. Kazdin, A. E., & Rabbitt, S. M. (2013). Novel models for delivering mental health services and reducing the burdens of mental illness. Clinical Psychological Science, 1(2), 170-191.
32. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., & Glaser, R. (2002). Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annual review of psychology, 53(1), 83–107.
33. Levy, N. (2014). Forced to be free? Increasing patient autonomy by constraining it. Journal of Medical Ethics, 40(5), 293–300.
34. Little, M., & Sayers, E. J. (2004). While there is life…: hope and the experience of cancer. Social science & medicine, 59(6), 1329-1337.
35. Loftus, T. J., Filiberto, A. C., Rosenthal, M. D., Arnaoutakis, G. J., Sarosi Jr, G. A., Dimick, J. B., & Upchurch Jr, G. R. (2020). Performance advantages for grit and optimism. The American Journal of Surgery, 220(1), 10-18.
36. Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., ... & Wittchen, H. U. (2020). The clinical characterization of adult patients with depression is aimed at the personalization of management. World Psychiatry, 19(3), 269-293.
37. Mani, M., Kavanagh, D. J., Hides, L., & Stoyanov, S. R. (2015). Review and evaluation of mindfulness-based iPhone apps. JMIR mHealth and uHealth, 3(3), e4328.
38. Mar, R. A., & Oatley, K. (2008). The function of fiction is the abstraction and simulation of social experience. Perspectives on psychological science, 3(3), 173-192.
39. Martínez-Martí, M. L., & Ruch, W. (2017). Character strengths predict resilience over and above positive affect, self-efficacy, optimism, social support, self-esteem, and life satisfaction. The Journal of Positive Psychology, 12(2), 110-119.
40. Nasir, A., Khan, A., Li, J., Naeem, M., Khalil, A. A., Khan, K., & Qasim, M. (2021). Nanotechnology is a tool for diagnostics and treatment of cancer. Current topics in medicinal chemistry, 21(15), 1360-1376.
41. Naylor, C., Das, P., Ross, S., Honeyman, M., Thompson, J., & Gilburt, H. (2016). Bringing together physical and mental health. King's Fund, 109(10), 364–366.
42. Olawade, D. B., Wada, O. Z., Odetayo, A., David-Olawade, A. C., Asaolu, F., & Eberhardt, J. (2024). Enhancing mental health with Artificial Intelligence: Current trends and prospects. Journal of medicine, surgery, and public health, 100099.
43. Ortega, M. A., García-Montero, C., Fraile-Martinez, O., Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Lahera, G., ... & Álvarez-Mon, M. (2022). Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology. Biology, 11(7), 973.
44. Ortega, M. A., García-Montero, C., Fraile-Martinez, O., Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Lahera, G., ... & Álvarez-Mon, M. (2022). Immune-mediated diseases from the point of view of psychoneuroimmunoendocrinology. Biology, 11(7), 973.
45. Panter-Brick, C., & Eggerman, M. (2011). Understanding culture, resilience, and mental health: The production of hope. In The social ecology of resilience: A handbook of theory and practice (pp. 369-386). New York, NY: Springer, New York.
46. Park, R., Shaw, J. W., Korn, A., & McAuliffe, J. (2020). The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life. Journal of Cancer Survivorship, pp. 14, 363–376.
47. Rahman, M. M., Behl, T., Islam, M. R., Alam, M. N., Islam, M. M., Albarrati, A., ... & Bungau, S. G. (2022). Emerging management approach for the adverse events of immunotherapy of cancer. Molecules, 27(12), 3798.
48. Rasool, S., Ali, M., Shahroz, H. M., Hussain, H. K., & Gill, A. Y. (2024). Innovations in AI-Powered Healthcare: Transforming Cancer Treatment with Innovative Methods. BULLET: Jurnal Multidisiplin Ilmu, 3(1), 118-128.
49. Rohan, J. M., & Verma, T. (2020). Psychological considerations in pediatric chronic illness: case examples. International Journal of Environmental Research and Public Health, 17(5), 1644.
50. Salmon, J. W., Thompson, S. L., Salmon, J. W., & Thompson, S. L. (2021). Big data: information technology as control over the profession of medicine. The Corporatization of American Health Care: The Rise of Corporate Hegemony and the Loss of Professional Autonomy, pp. 181–254.
51. Seiler, A., & Jenewein, J. (2019). Resilience in cancer patients. Frontiers in psychiatry, 10, 208.
52. Shareef, M. A., Kumar, V., Dwivedi, Y. K., Kumar, U., Akram, M. S., & Raman, R. (2021). A new health care system enabled by machine intelligence: Elderly people's trust or losing self control. Technological Forecasting and Social Change, p. 162, 120334.
53. Sharf, B. F., & Vanderford, M. L. (2003). Illness narratives and the social construction of health. In The Routledge Handbook of health communication (pp. 23-48). Routledge.
54. Standish, L. J., Malani, S. M., Lynch, K., Whinkin, E. J., McCotter, C. M., Lynch, D. A., & Aggarwal, S. K. (2023). Integrative oncology’s 30th anniversary: What have we achieved? A North American naturopathic oncology perspective. Integrative Cancer Therapies, p. 22, 15347354231178911.
55. Stein, K. D., Syrjala, K. L., & Andrykowski, M. A. (2008). Physical and psychological long‐term and late effects of cancer. Cancer, 112(S11), 2577-2592.
56. Tavakolpour, S., & Karami, F. (2021). Cancer nanomedicine: Special focus on cancer immunotherapy. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, 465-508.
57. Temel, J. S., Petrillo, L. A., & Greer, J. A. (2022). Patient-centered palliative care for patients with advanced lung cancer. Journal of Clinical Oncology, 40(6), 626–634.
58. Tribe, R., & Bell, D. (2018). Social justice, diversity, and leadership. The European Journal of Counselling Psychology, 7(1), 111-125.
59. Turk, D. C., Fillingim, R. B., Ohrbach, R., & Patel, K. V. (2016). Assessment of the psychosocial and functional impact of chronic pain. The Journal of Pain, 17(9), T21-T49.
60. van Dulmen, S., Sluijs, E., Van Dijk, L., de Ridder, D., Heerdink, R., & Bensing, J. (2007). Patient adherence to medical treatment: a review of reviews. BMC health services research, 7, 1-13.
61. Weeks, J. C., Catalano, P. J., Cronin, A., Finkelman, M. D., Mack, J. W., Keating, N. L., & Schrag, D. (2012). Patients' expectations about effects of chemotherapy for advanced cancer. New England Journal of Medicine, 367(17), 1616-1625.
62. Williams, D. R., Mohammed, S. A., Leavell, J., & Collins, C. (2010). Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Annals of the New York Academy of Sciences, 1186(1), 69–101.
63. Yazdanpanah, N., Mojtabavi, H., Ziaei, H., Pirkoohi, Z. R., Rayzan, E., & Rezaei, N. (2022). The clinical benefits of art therapy: definition, history, and outcomes with a focus on music therapy. In Multidisciplinarity and interdisciplinarity in health (pp. 457-482). Cham: Springer International Publishing.
Article Sidebar
Published
Aug 29, 2024
Article Details
How to Cite
THE PSYCHOLOGICAL LANDSCAPE OF CANCER IMMUNOTHERAPY, NAVIGATING THE EMOTIONAL CHALLENGES OF NOVEL TREATMENTS. (2024). Journal of Population Therapeutics and Clinical Pharmacology, 31(8), 1813-1828. https://doi.org/10.53555/w29rwd18
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Ayesha Tasawar
Department of Psychology, University of Sargodha, Punjab Pakistan
Iqra Bukhari
Department of Applied Psychology, Bahauddin Zakariya University Multan, Pakistan
Aqsa Waqar
Department of Clinical and Professional Psychology, Riphah International University Lahore, Pakistan
Huda Asif Malik
Department of Psychology, National College of Business Administration and Economics, Multan Pakistan
Saira Majid
Department of Clinical Psychology, The Superior University Lahore, Punjab, Pakistan
Atif Rasool
Department of Clinical Psychology, The Superior University Lahore, Punjab Pakistan
Musarrat parveen
Department of Psychology, Shaheed Benazir Bhutto Women University Peshawar Pakistan
Tayyba Jamil
Department of Applied Psychology, University of Sahiwal, Pakistan
Awais Ur Rahman
Department of Sociology, Abdul Wali Khan University Mardan, Pakistan
How to Cite
THE PSYCHOLOGICAL LANDSCAPE OF CANCER IMMUNOTHERAPY, NAVIGATING THE EMOTIONAL CHALLENGES OF NOVEL TREATMENTS. (2024). Journal of Population Therapeutics and Clinical Pharmacology, 31(8), 1813-1828. https://doi.org/10.53555/w29rwd18